Federation des caisses Desjardins du Quebec’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.8M Sell
205,779
-3,020
-1% -$670K 0.16% 107
2025
Q4
$47.7M Buy
208,799
+44,628
+27% +$10.2M 0.18% 98
2025
Q3
$38M Sell
164,171
-2,061
-1% -$420K 0.15% 115
2025
Q2
$30.9M Buy
166,232
+723
+0.4% +$134K 0.14% 129
2025
Q1
$34.7M Buy
165,509
+15,105
+10% +$2.94M 0.17% 111
2024
Q4
$26.7M Sell
150,404
-83,802
-36% -$15.4M 0.14% 130
2024
Q3
$46.2M Buy
234,206
+776
+0.3% +$145K 0.23% 72
2024
Q2
$40M Buy
233,430
+35,831
+18% +$5.94M 0.21% 81
2024
Q1
$35.4M Buy
197,599
+9,630
+5% +$1.66M 0.26% 85
2023
Q4
$29.1M Buy
187,969
+1,128
+0.6% +$164K 0.27% 82
2023
Q3
$27.9M Buy
186,841
+8,309
+5% +$1.22M 0.29% 76
2023
Q2
$24.1M Sell
178,532
-10,358
-5% -$1.52M 0.24% 95
2023
Q1
$30.1M Buy
188,890
+28,174
+18% +$4.31M 0.33% 65
2022
Q4
$26M Sell
160,716
-39,032
-20% -$5.98M 0.31% 77
2022
Q3
$26.8M Buy
199,748
+2,094
+1% +$300K 0.32% 72
2022
Q2
$30.3M Sell
197,654
-3,961
-2% -$605K 0.34% 67
2022
Q1
$32.7M Sell
201,615
-46,876
-19% -$6.81M 0.32% 71
2021
Q4
$33.6M Buy
248,491
+4,491
+2% +$531K 0.33% 67
2021
Q3
$26.3M Buy
244,000
+14,155
+6% +$1.62M 0.27% 73
2021
Q2
$25.9M Buy
229,845
+2,073
+0.9% +$233K 0.26% 74
2021
Q1
$24.7M Buy
227,772
+17,751
+8% +$1.9M 0.27% 73
2020
Q4
$22.5M Buy
210,021
+36,697
+21% +$3.53M 0.27% 74
2020
Q3
$15.2M Buy
173,324
+7,134
+4% +$672K 0.21% 97
2020
Q2
$16.3M Buy
166,190
+18,966
+13% +$1.67M 0.24% 85
2020
Q1
$11.2M Sell
147,224
-4,632
-3% -$395K 0.2% 92
2019
Q4
$13.4M Sell
151,856
-697
-0.5% -$57.9K 0.19% 91
2019
Q3
$11.6M Buy
152,553
+13,287
+10% +$911K 0.17% 101
2019
Q2
$10.1M Buy
139,266
+3,289
+2% +$259K 0.15% 121
2019
Q1
$11M Buy
135,977
+14,190
+12% +$1.16M 0.17% 111
2018
Q4
$11.2M Buy
121,787
+59,899
+97% +$5.27M 0.19% 96
2018
Q3
$5.85M Sell
61,888
-2,417
-4% -$229K 0.09% 199
2018
Q2
$5.96M Sell
64,305
-2,965
-4% -$290K 0.09% 207
2018
Q1
$6.37M Sell
67,270
-7,456
-10% -$819K 0.1% 190
2017
Q4
$7.23M Buy
74,726
+5,147
+7% +$485K 0.11% 179
2017
Q3
$6.18M Buy
69,579
+2,976
+4% +$227K 0.1% 191
2017
Q2
$4.83M Sell
66,603
-5,957
-8% -$400K 0.08% 216
2017
Q1
$4.73M Buy
+72,560
New +$4.56M 0.09% 198

Other funds holding ABBV

Federation des caisses Desjardins du Quebec's ABBV Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec reduced its AbbVie (ABBV) stake by 1.4% in Q1 2026, selling an estimated $670K and leaving 205,779 shares worth $44.8M. The position accounts for 0.16% of the portfolio, ranked #107.

Federation des caisses Desjardins du Quebec first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $47.7M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 205,779 shares of AbbVie worth $44.8M as of Q1 2026.
  • Federation des caisses Desjardins du Quebec sold 3,020 AbbVie shares in Q1 2026, an estimated $670K.
  • AbbVie made up 0.16% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #107 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
  • Federation des caisses Desjardins du Quebec's AbbVie position peaked at $47.7M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.